Bioelectronics is a goldmine cleverly disguised as an

New Post Public Reply Private Reply Replies (1) Message Board
WBeacham
399
Bioelectronics is a goldmine cleverly disguised as an economic dumpster fire on the brink of collapse and insolvency which is constantly attacked and denigrated by an army of pathetic bashtards who lack any semblance of rational critical thinking skills. The arguments are insane, stupidly insipid, and shrill. You sick sons-a-bitches couldn’t pass muster in a pre-k, dog&cat, dick&jane spelling bee let alone hold your own in an adult conversation. Your days of bloviating w/o consequence are over. You are pieces of human shit who have willingly sold themselves into intellectual and emotional prostitution.

Our medical system has become a ferocious battle between those who seek medical care that works and those whose moral and ethical depravity is on full display as in the recent senate hearings featuring RFK, Jr. tearing apart those big pharma hyprocrites whose pockets are stuffed w/ the money stolen from the victims of the deliberately malicious and intentionally perpetrated opioid onslaught. These politicians, the CEOs and their lobbyists, the AMA, the vaccine and opioid manufacturers have the blood of millions on their hands. I would hate to be them when they go to meet their Maker. Their judgment will be as swift as it is devastating. God will NOT have mercy on your blood-stained souls.

Bioelectronics has a pain relief product that has not one single recognizable negative side effect in over 20 yrs of use. Name one FDA approved, AMA advertised, big pharma pushed drug that can make the same claim. BIEL’s survival is proof positive of the insanely huge market waiting for them to claim their victory. Within the system there are those people who know full well what is happening. A revolution is taking place as I live and breathe. We, Bioelectronics the company, the loyal shareholders, the general public, the companies who are quietly making the Bioelectronics transition happen, will change the status quo forever. We are the business end of the spear and they fear us. We are coming and they know it. Their efforts to lie, cheat, steal, deceive, defraud, and manipulate are at a fever pitch. Their vane attempts to wrap themselves up in ostentatious displays of philanthropy and righteousness to hide their guilt are shameful and hollow.

Bashtards are the very worst of the sleeziest, real guttersnipes. They openly accuse Dr. Sree Koneru of being a fool as if he so stupid he would jeopardize his career and family to align himself with a presumed sham of a company. Viant, and all those people and institutions who are working w/ them (behind the scenes) know exactly what they are doing. A $200,000 investment for a 1 billion share stake is pocket change for a massive windfall return on investment. You think the CEO is nothing but an inept, money-grubbing bitch? Wait and see, pal, wait and see. We are kicking your ass and you don’t even know the fight is on. You get away with your baseless accusations b/c we lack the social fabric to hold you to account for your actions. Big Pharma is an enemy w/o limits or consequences. Therefore, discretion during preparation is paramount.

I, as an individual, am betting we win. And win big, we shall. I wish all my fellow investors the very same. The personal money gain is only part of the success. Moving forward in a position to help family & friends and knowing I was part of changing life for the better for millions of pain sufferers worldwide is supreme gratification. The battle that has been waged for a hundred years against hapless victims is coming to a Dénouement. Books to read are, Turtles All The Way Down, Dissolving Illusions, and Beauchamp or Pasteur?: A Lost Chapter in the History of Biology. Become part of the solution. What have you done today?

Quote:
THESE are the times that try men’s souls. The summer soldier and the sunshine patriot will, in this crisis, shrink from the service of their country; but he that stands it now, deserves the love and thanks of man and woman.

"Sic parvis magna" - Greatness from small beginnings

All the best, WBeacham

BioElectronics Corporation (BIEL) Stock Research Links

BIEL Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

PathoSearch: A New Era in Pathology With Visual Search

Updated Category News Views 8

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

Continue Reading
Damp or Dry: The Battle for Healthy Air in Colorado

Updated Category News Views 4

The Hidden Cost of Colorado's Dry Air Dry climate isn't just a seasonal inconvenience—it's a real hidden cost to living comfortably and healthily in Colorado. With winters colder than a brass monkey's tail and summers that don't offer much relief in terms of humidity, your home's air quality is on the front line. So, what's the financial tale here, and how do you come...

Continue Reading
Delhi Pushes Innovation Against Dryland Challenges

Updated Category News Views 5

Evolution of South-South Agricultural Cooperation Let's just say if there's a time to shine a spotlight on the arid lands of our world, it's now. The Global Drylands Congress 2026 in New Delhi put a sharp focus on scaling agricultural innovation across these thirsty regions. With climate change breathing down our necks, talking shop about food security isn't just for show...

Continue Reading
New 2027 Jeep Wrangler JL-2A: A Blast from the Past

Updated Category News Views 4

Revisiting a Prized Legacy: The 2027 Jeep Wrangler JL-2A Sometimes, what’s new is really just a nod to what’s old—and nowhere is this more so than with the 2027 Jeep Wrangler JL-2A. In the grand parade of automotive history, Jeep's latest creation is more than just a vehicle; it's a time machine that cruises on its historic lineage while strapping on all the modern...

Continue Reading
Larry Ellison's Moves Signal Confidence in Oracle's Future

Updated Category News Views 5

Unraveling Ellison's Bold Decision There's nothing like a sudden shift from a tech titan to make Wall Street sit up and take notice. Today, we got the word that Larry Ellison, Oracle's big gun as Executive Chair and CTO, has pulled the plug on his plan to sell Oracle stock. No dice, no distance covered under that plan. And he's made it crystal clear—selling isn't on his...

Continue Reading
PureHealth's Acid Reflux Solutions: An Investor's Insight

Updated Category News Views 2

Digestive Wellness: The Emerging Opportunity Some days, it feels like everybody's got a gripe about their gut. You nod along at the lunch counter, folks buzzing about digestive this and acid that. But when PureHealth Research pops up with their fancy supplements, well, even the stock market's noisier nonsense starts sounding a bit quieter. They're banking big on the...

Continue Reading
SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Updated Category News Views 9

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...

Continue Reading
Countries Eye New Investment Paths at CIFIT 2026

Updated Category News Views 4

Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...

Continue Reading
ARTiSTORY's Strategic Advance in Cultural IP Licensing

Updated Category News Views 6

Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...

Continue Reading
IASLC Boosts Global Thoracic Cancer Collaboration

Updated Category News Views 4

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...

Continue Reading

Top 5 Most Recently Viewed Articles

Gentherm's Q2 2025 Results Highlight Strong Performance & Future

Updated Category News Views 132

Gentherm's Financial Performance for Second Quarter 2025 Gentherm, a global innovator in thermal management technologies, reported outstanding financial outcomes for the second quarter of 2025. The company's revenue reached $375 million, underscoring its strength in the automotive sector, particularly within Climate and Comfort Solutions. Record Achievements and New...

Continue Reading
DEALMining Surpasses 6.8 Million Users with Exciting Rewards

Updated Category News Views 237

DEALMining Achieves Major User Milestone In a significant accomplishment, DEALMining has proudly announced that its user base has exceeded 6.8 million globally, marking its status as one of the fastest-growing compliant cloud mining platforms in the world. This impressive growth showcases DEALMining's successful outreach across more than 200 countries and regions, as the...

Continue Reading
Investigation Launched into Aehr Test Systems for Investors' Losses

Updated Category News Views 218

Investigation into Aehr Test Systems, Inc. Focused on Investor Protection The Law Offices of Frank R. Cruz are actively investigating Aehr Test Systems, Inc. (NASDAQ: AEHR) in light of significant concerns raised regarding the company’s adherence to federal securities laws. This investigation comes as a response to alarming financial disclosures made public by the...

Continue Reading
Vivoryon Therapeutics to Share Insights on 2024 Performance

Updated Category News Views 176

Vivoryon Therapeutics N.V. Set to Report Financial Outcomes Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY; NL00150002Q7) is gearing up to unveil its financial results for the entirety of 2024, along with insights into its operational achievements. The highly anticipated announcement is scheduled for April 29, 2025, aiming to shed light on the company’s progress in...

Continue Reading
Navigating Economic Trends: Insights for Savvy Investors

Updated Category News Views 110

Understanding the Economic Climate In finance, a stable economy is often described as a "Goldilocks" economy, where conditions are ideal for investments to flourish. Lately, we have witnessed an economy that consistently surpasses expectations, putting worries about downturns to rest. The Search for Economic Balance Investors are keen to find that sweet spot where...

Continue Reading